v3.22.2.2
Statements of Changes in ShareHolders' Equity (Deficit) (Parenthetical) - shares
 12 Months Ended
Oct. 25, 2021
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Sale of 8,625,000 Units through public offering, shares   1,437,500    
Common stock shares outstanding   2,156,250 2,448,500 2,156,250
Sponsor [Member]        
Sale of 8,625,000 Units through public offering, shares 718,750      
Common stock shares outstanding 2,156,250      
Over-Allotment Option [Member]        
Stock forfeiture   187,500   281,250
Common Stock [Member]        
Sale of 8,625,000 Units through public offering, shares [1]     8,625,000  
Stockholders' equity, other shares [1]     292,250  
[1] As of July 31, 2021, this number includes an aggregate of up to 281,250 shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). As a result of the full exercise of the over-allotment option by the underwriters upon the consummation of the IPO, these shares are no longer subject to forfeiture (see Note 7).